Skip to main content

Cardlytics, Inc.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

CDLX$1.95-11.0%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. Other Information

We are party to an amended and restated loan and security agreement, dated as of September 30, 2024, with Banc of California (as amended to date, the "2018 Line of Credit"), which provides for an asset-based revolving line of credit. Subsequent to the end of the third quarter of 2026, we and Banc of California (formerly Pacific Western Bank) entered into an amendment to the 2018 Line of Credit (the “Amendment”) that, among other things, decreases the required minimum level of cumulative Adjusted EBITDA for the year ending December 31, 2026.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, a copy of which is attached as Exhibit 10.2 to this Quarterly Report on Form 10-Q and incorporated by reference herein.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.